Andrea F. Wainer - 13 Dec 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Signature
/s/ Andrea F. Wainer by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
13 Dec 2021
Net transactions value
-$1,340,500
Form type
4
Filing time
15 Dec 2021, 17:38:11 UTC
Previous filing
08 Dec 2021
Next filing
21 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $329,000 +7,000 +14% $47.00 56,782 13 Dec 2021 Direct
transaction ABT Common shares without par value Options Exercise $288,000 +7,500 +13% $38.40 64,282 13 Dec 2021 Direct
transaction ABT Common shares without par value Sale $1,957,500 -14,500 -23% $135.00 49,782 13 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -7,000 -24% $0.000000 21,726 13 Dec 2021 Common Shares 7,000 $47.00 Direct F1
transaction ABT Option (right to buy) Options Exercise $0 -7,500 -33% $0.000000 15,000 13 Dec 2021 Common Shares 7,500 $38.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).